ROYAL BANK OF CANADA - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 51 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q3 2016$3,000
-87.5%
5,000
-58.3%
0.00%
Q2 2016$24,000
-57.9%
12,000
-48.9%
0.00%
Q1 2016$57,000
-68.3%
23,4920.0%0.00%
Q4 2015$180,000
+38.5%
23,492
-4.1%
0.00%
Q3 2015$130,000
-43.5%
24,502
-4.7%
0.00%
Q2 2015$230,000
+23.7%
25,702
-12.6%
0.00%
Q1 2015$186,000
-4.6%
29,392
-12.0%
0.00%
Q4 2014$195,000
-17.4%
33,392
-2.9%
0.00%
Q3 2014$236,000
-32.0%
34,400
+42.1%
0.00%
Q2 2014$347,000
+69.3%
24,214
+22.9%
0.00%
Q1 2014$205,00019,7000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2016
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,227,832$856,0000.04%
FT Options LLC 15,000$10,0000.01%
BLUESTEIN R H & CO LLC 112,200$78,0000.01%
SABBY MANAGEMENT, LLC 203,097$142,0000.01%
TWO SIGMA SECURITIES, LLC 16,701$12,0000.00%
Klingman & Associates, LLC 10,000$7,0000.00%
TFS CAPITAL LLC 13,627$10,0000.00%
OPPENHEIMER & CO INC 75,500$53,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 103,900$72,0000.00%
Virtu KCG Holdings LLC 48,827$34,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders